Back to search

Democritus University of Thrace (DUTH)

Ανίχνευση μεταλλάξεων στα γονίδια MLH1, MSH2 και APC σε ασθενείς με οικογενειακό ιστορικό καρκίνου του παχέος εντέρου και άλλων μορφών καρκίνου που συνδέονται με τα σύνδρομα HNPCC και FAP

Abstract

dc:description

Germline mutations in the DNA mismatch repair genes, namely MLH1, MSH2, MSH6 and PMS2, as well as in the tumour-suppressor gene APC predispose to Lynch syndrome and Familial Adenomatous Polyposis syndrome (FAP), respectively. Direct sequencing was applied for the detection of point mutations as well as small insertions/ deletions in the MLH1 and MSH2 genes, while large genomic rearrangements in the MLH1, MSH2 and APC genes were determined through Multiplex Ligation dependent Probe Amplification (MLPA). 24 families, out of which 16 fulfilled the Amsterdam criteria, were screened for the presence of pathogenic point mutations in the MLH1 and MSH2 genes. Seven deleterious aberrations were detected in 9 out of 16 AMS+ families. Three of these alterations are novel. Moreover, 32 families out of which 20 did not carry deleterious alterations, were screened for the presence of large genomic rearrangements in the MLH1 and MSH2 genes. One single exon deletion and one single exon duplication located in the MLH1 gene as well as one single exon duplication located in the MSH2 gene were detected through MLPA in three discrete AMS+ families. The deletion was further confirmed by long range PCR, while its breakpoints were determined through direct sequencing. Seven APC mutation-negative FAP/AFAP families were screened for the presence of genomic rearrangements through MLPA but none of them carried any deletion or duplication. In conclusion, the MLH1 and MSH2 mutational spectrum in the context of the Greek population as it has been shaped by the present study is discrete and quite heterogeneous. Furthermore, this study demonstrated the significance of compiling a thorough family history for the clinical diagnosis of Lynch syndrome as the detection rate among AMS+ families is 56,25%. Regarding the “negative” families with a relatively strong family history, mutations in other genes or other types of aberrations not detectable by the molecular approaches used in this study may predispose to the development of cancer.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Thodi, Georgia
  • Θώδη, Γεωργία

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29942

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Thodi, Georgia; Θώδη, Γεωργία. Ανίχνευση μεταλλάξεων στα γονίδια MLH1, MSH2 και APC σε ασθενείς με οικογενειακό ιστορικό καρκίνου του παχέος εντέρου και άλλων μορφών καρκίνου που συνδέονται με τα σύνδρομα HNPCC και FAP. Democritus University of Thrace (DUTH), 2010. http://hdl.handle.net/10442/hedi/29942